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Abstract
Objective: To describe the pulmonary function in children and adolescents with postinfectious bronchiolitis oblite-
rans (PIBO), as well as to evaluate potential risk factors for severe impairment of pulmonary function. Methods: The 
pulmonary function of 77 participants, aged 8-18 years, was assessed by spirometry and plethysmography. The 
following parameters were analyzed: FVC; FEV1; FEF25-75%; FEV1/FVC; RV; TLC; RV/TLC; intrathoracic gas volume; 
and specific airway resistance (sRaw). We used Poisson regression to investigate the following potential risk factors 
for severe impairment of pulmonary function: gender; age at first wheeze; age at diagnosis; family history of 
asthma; tobacco smoke exposure; length of hospital stay; and duration of mechanical ventilation. Results: The 
mean age was 13.5 years. There were pronounced decreases in FEV1 and FEF25-75%, as well as increases in RV 
and sRaw. These alterations are characteristic of obstructive airway disease. For the parameters that were the 
most affected, the mean values (percentage of predicted) were as follows: FEV1 = 45.9%; FEF25-75% = 21.5%; 
RV = 281.1%; RV/TLC = 236.2%; and sRaw = 665.3%. None of the potential risk factors studied showed a 
significant association with severely impaired pulmonary function. Conclusions: The patients with PIBO had 
a common pattern of severe pulmonary function impairment, characterized by marked airway obstruction and 
pronounced increases in RV and sRaw. The combination of spirometric and plethysmographic measurements can 
be more useful for assessing functional damage, as well as in the follow-up of these patients, than are either of 
these techniques used in isolation. Known risk factors for respiratory diseases do not seem to be associated with 
severely impaired pulmonary function in PIBO. 
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Resumo
Objetivo: Descrever a função pulmonar de crianças e adolescentes com bronquiolite obliterante pós-infecciosa 
(BOPI) e avaliar potenciais fatores de risco para pior função pulmonar. Métodos: A função pulmonar de 
77 participantes, com idades de 8-18 anos, foi avaliada por meio de espirometria e pletismografia. Os seguintes 
parâmetros foram analisados: CVF, VEF1, FEF25-75%, VEF1/CVF, VR, CPT, VR/CPT, volume de gás intratorácico e 
specific airway resistance (sRaw, resistência específica das vias aéreas). Foi utilizada a regressão de Poisson para 
investigar os seguintes potenciais fatores de risco para pior função pulmonar: sexo, idade do primeiro sibilo, idade 
ao diagnóstico, história familiar de asma, exposição ao tabaco, tempo de hospitalização e tempo de ventilação 
mecânica. Resultados: A idade média foi de 13,5 anos. Houve uma diminuição importante de VEF1 e FEF25-75%, 
assim como um aumento de VR e sRaw, característicos de doença obstrutiva das vias aéreas. Os parâmetros mais 
afetados e as médias percentuais dos valores previstos foram VEF1 = 45,9%; FEF25-75% = 21,5%; VR = 281,1%; VR/
CPT = 236,2%; e sRaw = 665,3%. Nenhum dos potenciais fatores de risco avaliados apresentou uma associação 
significativa com pior função pulmonar. Conclusões: As crianças com BOPI apresentaram um padrão comum de 
comprometimento grave da função pulmonar, caracterizado por uma obstrução importante das vias aéreas e um 
expressivo aumento de VR e sRaw. A combinação de medidas espirométricas e pletismográficas pode ser mais útil 
na avaliação do dano funcional, assim como no acompanhamento desses pacientes. Fatores de riscos conhecidos 
para doenças respiratórias não parecem estar associados a pior função pulmonar em BOPI.
Descritores: Testes de função respiratória; Obstrução das vias respiratórias; Bronquiolite obliterante.
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Methods
This was a cross-sectional study involving 
children and adolescents (8-18 years of age) 
with PIBO, in Brazil and Chile. The participants 
were periodically monitored at one of two 
tertiary care pediatric pulmonology outpatient 
clinics: that of the Hospital da Criança Santo 
Antonio, located in the city of Porto Alegre, 
Brazil; or that of the Centro de Referencia de 
Salud del Hospital El Pino, located in the city 
of Santiago, Chile. The staff at both clinics 
have extensive clinical experience in diagnosing 
and monitoring pediatric patients with PIBO, 
having done so for more than 15 years. For the 
purposes of this study, we analyzed the results of 
pulmonary function tests carried out in 2007. Of 
the 83 patients initially eligible for inclusion in 
the study, 5 presented with pulmonary function 
test results that did not meet the acceptability/
reproducibility criteria of the American Thoracic 
Society/European Respiratory Society (ATS/
ERS) and another declined to participate in the 
study. Those 6 patients were therefore excluded. 
Consequently, the final sample consisted of 
77 patients: 41 in Brazil and 36 in Chile.
The criteria for a diagnosis of PIBO were 
based on previous reports(1,8,13,14) and included 
all of the following: 
•	acute,	severe	bronchiolitis/viral	pneumonia	
during the first 3 years of life in children 
who had previously been healthy
•	evidence	 of	 persistent	 airway	 obstruction	
after the acute event (identified either 
by physical examination or by pulmonary 
function testing) that was unresponsive to at 
least two weeks of treatment with systemic 
corticosteroids and bronchodilators
•	chest	X-ray	 findings	 indicative	of	chronic	
lung disease (e.g., hyperinflation, 
atelectasis, airway wall thickening, and 
bronchiectasis)
•	mosaic	pattern	and	air	trapping	on	chest	CT
•	exclusion	of	other	conditions	that	progress	
to permanent respiratory symptoms, 
including chronic lung diseases such 
as tuberculosis, cystic fibrosis, and 
bronchopulmonary dysplasia, as well as 
immunodeficiency and alpha-1-antitrypsin 
deficiency
Spirometric parameters—FVC, FEV1, 
FEF25-75%, and FEV1/FVC—and plethysmographic 
parameters—intrathoracic gas volume (ITGV), 
Introduction
Bronchiolitis obliterans (BO) is an uncommon 
form of chronic lung disease that follows a 
severe insult to the lower respiratory tract. From 
the pathological perspective, it is characterized 
by partial or complete luminal obstruction of 
the small airways by scar tissue, secondary to 
inflammation and fibrosis.(1,2) Because organ 
transplantation has improved survival in patients 
with lung disease patients, the incidence of 
BO as a manifestation of graft rejection has 
increased.(3) In children and adolescents, however, 
the most common form of BO, especially in 
developing countries, is postinfectious BO 
(PIBO).(4)
There have been reports of PIBO on most 
continents, interesting data coming from South 
American countries and corresponding to the 
adenovirus epidemics that occurred during the 
1990s.(4-6) In PIBO, as in other chronic lung 
diseases, determining pulmonary function is 
crucial for the diagnosis, as well as for classifying 
the severity of the condition and monitoring 
its progression. Unfortunately, there is only 
sparse information in the literature regarding 
the pulmonary function of patients with PIBO. 
Two studies (both conducted by the same 
research group) evaluated pulmonary function 
in infants with PIBO.(5,7) Those two studies 
produced consistent results, since both included 
a representative number of patients. That is 
not the case for studies involving children and 
adolescents with PIBO; the few articles providing 
lung function data usually have small sample 
sizes and different methodology or focus, which 
precludes an appropriate characterization of 
LF.(8-11) This effectively prevents us from drawing 
reliable conclusions regarding the characteristics 
of pulmonary function in this age bracket.
Profiling the pulmonary function of children 
and adolescents with PIBO could give us a better 
insight of the long-term respiratory effects of 
the disease. This could be of interest not only 
to those studying and treating patients with 
PIBO, but also to those in the field of lung 
transplantation, since the histopathological 
similarities between transplant and PIBO(12) could 
translate to similarities in pulmonary function. 
The  objective of this study was to describe the 
pulmonary function of children and adolescents 
with PIBO and to evaluate the potential risk 
factors for severe impairment of pulmonary 
function.
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by a forced expiratory maneuver in which the 
patient exhaled down to RV. The effort with 
the greatest VC and the best shutter maneuver, 
which included the loop closest to the pressure-
volume axis, was considered the best effort. 
Spirometric measurements were taken after the 
patient had rested for 5 min. Appropriate values 
were selected from the best three acceptable and 
reproducible FVC maneuvers, and the selected 
maneuver was the one with the greatest sum of 
FVC and FEV1.
We employed the reference values and 
equations devised by Perez-Padilla et al. and 
Zapletal et al. for spirometry and plethysmography, 
respectively.(18,19) All pulmonary function data 
are expressed as a percentage of the predicted 
reference value. The severity of impairment 
for spirometric parameters was based on FEV1 
according to the ATS/ERS recommendations,(20) 
and the normality ranges accepted for volumes 
were those recommended by the Sociedad 
Española de Neumología y Cirugía Torácica 
(Spanish Society of Pulmonology and Thoracic 
Surgery).(21) We defined severely impaired 
pulmonary function as that classified as severe 
or very severe impairment, according to the ATS 
criteria.(20)
Continuous variables are expressed as mean 
and 95% CI, whereas categorical variables are 
expressed as absolute and relative frequency. 
The adjusted prevalence ratios of potential risk 
factors for severe impairment of pulmonary 
function were calculated by Poisson regression 
with robust error variance in bivariate and 
multivariate analyses. This was followed by an 
interactive procedure, initially considering all 
covariates with a p value < 0.10 in a multiple 
regression model. The covariates with the 
RV, TLC, RV/TLC, and specific airway resistance 
(sRaw)—were measured in accordance with 
international recommendations for acceptability 
and reproducibility.(15,16) The pulmonary function 
parameters were measured only if patients 
had been free of respiratory exacerbations 
and clinically stable for at least two weeks. 
Short-acting and long-acting β2 agonists were 
withheld for, respectively, 12 h and 48 h prior 
to the tests, although inhaled corticosteroids 
were maintained as prescribed. Before any tests 
were conducted, the patients were familiarized 
with the basic maneuvers for spirometric and 
plethysmographic measurements.
At each facility, the measurements were 
conducted by an accredited laboratory technician. 
All measurements were taken in the morning 
(plethysmography followed by spirometry). 
Both centers used the same type of spirometer 
(MasterScreen Body, with software, v4.3; Jaeger, 
Würtzburg, Germany), which was calibrated daily 
using a 3-L syringe, and measurements were 
electronically corrected to body temperature and 
pressure, saturated conditions.(15-17)
During the plethysmography, the patients 
were instructed to breathe calmly through a 
mouthpiece until reaching a stable end-expiratory 
level. The shutter then closed automatically for 
2-3 s while the patients performed a series of 
shallow panting maneuvers (against 0.5-1.0 Hz 
of resistance), with both hands supporting their 
cheeks. The results of three to five technically 
satisfactory maneuvers were registered for 
subsequent analysis. The shutter was opened, 
and the patients slowly exhaled as completely as 
possible (to allow the expiratory reserve volume 
to be determined). Subsequently, the patients 
slowly inhaled up to TLC, and this was followed 
Table 1 - Demographic data of the participants, by country.
Variable Brazil Chile Both countries
(n = 41) (n = 36) (n = 77)
Age,a years 11.5 (10.7-12.3) 15.1 (14.0-16.3) 13.3 (12.4-14.0)
Height,a cm 144.6 (139.7-149.5) 157.3 (152.6-162.0) 150.5 (146.9-154.1)
BMI,a kg/m2 17.9 (16.9-18.9) 21.4 (20.0-22.9) 19.5 (18.6-20.5)
Age at diagnosis,a months 12.2 (9.6-14.6) 10.78 (8.2-13.3) 11.4 (9.7-13.2)
0-6b 7 (17.1) 9 (25.0) 16 (20.8)
7-12b 22 (53.6) 17 (47.2) 39 (50.6)
13-24b 10 (24.4) 9 (25.0) 19 (24.7)
>24b 2 (4.9) 1 (2.8) 3 (3.9)
Male genderb 31 (75.6) 19 (52.8) 50 (64.9)
aValues expressed as mean (95% CI). bValues expressed as n (%).
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RV, RV/TLC, and sRaw) were markedly high, with 
the exception of TLC, which was within normal 
limits.
In the regression model, none of the potential 
risk factors demonstrated a significant association 
with severely impaired pulmonary function. There 
was a moderate correlation between RV/TLC and 
FEV1	(r	=	−0.657, p < 0.001) and between RV/
TLC and FEF25-75%	(r	=	−0.669,	p	<	0.001).
Discussion
The present study describes pulmonary 
function in one of the largest samples of 
pediatric patients with PIBO evaluated to date. 
Our results show that, at both of the facilities 
involved, the children and adolescents with PIBO 
presented with moderate to very severe airway 
obstruction.(20) This impairment, which probably 
reflects major chronic damage of the medium 
and small airways, is characterized by decreased 
expiratory airflow, together with increased RV 
and sRaw.
In order to elucidate the great impact that 
PIBO has on the major morphological and 
functional components of the respiratory system, 
a combination of methods must be employed. 
One such method is pulmonary function testing, 
which allows us to assess, in a relatively practical 
and noninvasive manner that is most suitable 
for diagnostic and follow-up routines, how the 
viscoelastic and flow-resistive properties of the 
system are impaired.(22)
Because PIBO is a rare disease with a relatively 
small number of patients in any given country, 
the use and results of pulmonary function testing 
highest p values were removed from the model, 
which was then recalculated. The final model 
comprised only covariates with a p value < 0.10. 
We included the following variables as potential 
risk factors: ggender; age at first wheeze; 
age at diagnosis; family history of asthma; 
tobacco smoke exposure; length of hospital 
stay; and duration of mechanical ventilation. 
The correlation between RV/TLC and FEV1, as 
well as that between RV/TLC and FEF25-75%, was 
assessed using Pearson’s correlation coefficient 
(r). The level of statistical significance was set 
at p < 0.005.
The study was approved by both local 
research ethics committees. The parents or 
legal guardians of the participants gave written 
informed consent, and the participating patients 
verbally agreed to be included in the study.
Results
The demographic data are shown in Table 1. 
In both groups, there was a predominance of 
males (Brazil: 75.6%; Chile: 52.8%). The overall 
means (and the group means for Brazil and Chile, 
respectively) were as follows: age, 13.3 years 
(11.5 and 15.1 years); height, 150.5 cm (144.6 
and 157.3 cm); and BMI, 19.5 kg/m2 (17.9 and 
21.4 kg/m2). The onset of the disease occurred 
between 1 and 24 months of age in most of the 
patients (97% of the group in Brazil and 97% of 
the group in Chile).
Table 2 shows the pulmonary function 
parameters. In both groups, the mean values 
of all spirometric variables, especially FEV1 and 
FEF25-75%, were low. Correspondingly, the mean 
values of most plethysmographic variables (ITGV, 
Table 2 - Pulmonary function parameters of the participants, by country.
Parametera Brazilb Chileb Both countriesb
(n = 41) (n = 36) (n = 77)
FVC 61.7 (56.9-66.4) 72.5 (68.2-76.8) 66.8 (63.4-70.2)
FEV1 42.5 (37.6-47.0) 49.7 (44.7-54.8) 45.9 (42.4-49.4)
FEF25-75% 19.9 (16.0-23.8) 23.4 (19.1-27.7) 21.5 (18.6-24.4)
FEV1/FVC 67.6 (63.1-72.1) 66.8 (62.5-71.1) 67.2 (64.1-70.3)
TLC 116.8 (113.1-120.5) 112.5 (10.8-117.1) 116.8 (113.2-120.5)
ITGV 162.7 (154.0-171.4) 144.5 (134.6-154.3) 162.7 (154.0-171.4)
RV 281.1 (258.6-303.7) 231.0 (203.2-258.7) 281.1 (258.6-303.7)
RV/TLC 236.2 (222.5-250.40) 200.9 (184.7-217.1) 236.2 (222.5-250.0)
sRaw 746.6 (597.5-895.7) 572.8 (431.9-713.6) 665.3 (562.5-768.2)
ITGV: intrathoracic gas volume; and sRaw: specific airway resistance. aValues expressed as percentage of the predicted 
value. bValues expressed as mean (95% CI).
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when airflow obstruction becomes more severe 
as a result of decreased lung elastic recoil or 
changes in dynamic mechanisms, ITGV, RV, TLC, 
and RV/TLC tend to increase.
We found only two studies evaluating lung 
volumes in pediatric patients with PIBO.(9,10) 
We pooled the data of their collective sample 
(n = 25) and, disregarding any methodological 
differences, found that all of the patients 
showed a marked increase in RV. In our study 
sample (n = 77), we also identified patients 
with reduced FVC. However, in those patients, 
the TLC was also considerably above 80% of 
the predicted value, with a noticeable increase 
in RV and RV/TLC. These lung volume data, 
obtained by plethysmography, leave no doubt as 
to the obstructive nature of PIBO. In addition, 
we found that, overall, RV/TLC presented 
good correlations with two of the spirometric 
parameters, FEV1 and FEF25-75%, indicating that 
the degree of hyperinflation paralleled the 
severity of airway obstruction. This situation 
can lead to progressive clinical consequences, 
such as a permanent need for oxygen therapy or 
impaired quality of life.
Although FEV1/FVC and FEV1 are the 
spirometric parameters most often employed 
in order to determine airway obstruction, 
FEF25-75% has also been considered a relevant early 
indicator of this abnormality, since it appears to 
show a proportionately greater reduction than 
does FEV1 or FEV1/FVC.
(9,10,20) Our results show 
that all of the patients had abnormal values 
for FEF25-75% and FEV1, the FEF25-75% value 
being half of that obtained for FEV1. This is in 
agreement with the current recommendations 
for diagnosing bronchiolitis obliterans syndrome 
(BOS) in transplant patients. Since FEF25-75% has 
been found to deteriorate sooner after BOS onset 
than does FEV1,
(3) the criteria for early detection 
of BOS now include a decline in FEF25-75%, as 
well as a decrease in FEV1.
(26) Because FEF25-75% 
presents considerable variability, as evidenced 
in a recent study,(27) its routine use in clinical 
practice has been controversial. However, its 
considerable and consistent reduction in our 
patients with PIBO suggests that FEF25-75% should 
be considered together with the established duo 
of FEV1 and FEV1/FVC to define the extent of 
functional damage, as well as in the routine 
follow-up of such patients. The fact that it is 
obtained simultaneously with other spirometric 
in PIBO patients have been addressed in only a 
few studies, six of which have been notable: 
•	Studying	 a	 sample	 of	 13	 infants	 in	
Argentina, Teper et al. suggested that the 
functional impairment caused by PIBO is 
established at its early stages.(7)
•	Kim	 et	 al. described the pulmonary 
function of 14 children within a study 
group of 31 children with PIBO in the USA 
and South Korea. The authors found that 
all 14 presented with severe, fixed airway 
obstruction.(9)
•	Castro-Rodriguez	et	al.,	using	the	impulse	
oscillometry technique, found evidence 
of peripheral airway dysfunction in 18 
preschool children in Chile.(23)
•	Cazzato	 et	 al.	 conducted	 a	 longitudinal	
study of the pulmonary function of 14 
children in Italy and found an annual 
decline of 1% in the predicted values of 
FEV1, FEV1/FVC and FEF25-75%.
(10)
•	In	 Brazil,	 Mattiello	 et	 al.	 assessed	 the	
functional capacity of 20 children during 
cardiopulmonary exercise testing and 
compared the results with those of 
conventional pulmonary function testing. 
The children presented with reduced 
oxygen consumption, which correlated 
positively with FVC, FEV1, and RV/TLC.
(11)
•	Mattiello	 et	 al.	 also	 studied	 a	 group	 of	
21 children in Brazil and showed that the 
CT findings in early life seem to predict 
severely impaired pulmonary function a 
decade later.(24)
Our results corroborate and expand upon a 
conclusion drawn on the basis of those studies: 
the functional hallmark of the disease is marked 
airway obstruction with air trapping. Another 
group of authors described PIBO patients 
with a restrictive or mixed pattern of obstruction.
(25) However, those authors based their analysis 
solely on a reduced FVC that was associated with 
a normal or low FEV1/FVC ratio.
(25) Therefore, 
their finding can be explained in the context of 
a considerable airway obstruction that leads to 
pronounced air trapping, the degree of which is 
best determined through the assessment of lung 
volumes.(20) The ATS and ERS both recommend 
the determination of lung volumes in patients 
with obstructive lung diseases, such as PIBO, 
because it allows a better understanding of the 
underlying respiratory impairment.(16,20) In fact, 
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parameters and through the same technique 
strengthens its feasibility.
One limitation of our study is that our two 
groups of patients with PIBO were each from a 
different country. However, since both of those 
countries are in the southern portion of South 
America, there are geographic, ethnic, and 
nutritional similarities between the two groups. In 
addition, they all developed the disease at similar 
(young) ages, corresponding to simultaneous 
regional bursts of severe adenovirus respiratory 
infections during the early and mid 1990s.(28) 
Furthermore, the measurements corresponded 
to pulmonary function testing obtained during 
the same year, both pulmonary function testing 
laboratories are board certified, both follow the 
ATS/ERS recommendations, and both used the 
same apparatus and software. The group results 
are presented together with those of the sample 
as a whole, and it is clear that the two patient 
groups were similar in terms of pulmonary 
function.
Our sample size was adequate to run the 
statistical model used, and our analyses revealed 
that none of the factors studied constituted a risk 
for severe impairment of pulmonary function.
We believe that the value of our study lies 
in the large number of participants and the 
broad age range of the sample, as well as in 
the use and analysis of an extensive number 
of pulmonary function variables. These aspects 
allowed us to obtain data that are consistent and 
reliable. Our data can inform decisions regarding 
the evaluation and treatment of patients with 
PIBO, as well as those regarding future studies in 
children or adolescents with post-transplant BO.
In conclusion, pediatric patients with PIBO 
have a common pattern of severe pulmonary 
function impairment, characterized by 
marked airway obstruction and a pronounced 
increase in RV and sRaw. Our results suggest 
that the combined use of spirometric and 
plethysmographic measurements is more useful 
than is that of each method alone in assessing 
functional damage at a given time and in the 
follow-up of children or adolescents suffering 
from this rare disease.
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